Axon Therapies Announces Chad Hoskins As Chief Executive Officer
SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ -- Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead the company as it transitions from early development towards regulatory clearance and commercialization of its novel heart failure treatment, splanchnic ablation for volume management (SAVM), using the Satera™ Ablation System. "Axon is poised to disrupt the heart failure market by treating a root cause of the disease ...